CD19/BCMA CAR-T Cell Therapy
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for CD19/BCMA CAR-T Cell Therapy, covering 2025-01-21 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH [Phase 1, Phase 2]